Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−120.31 MXN
−2.29 B MXN
5.25 B MXN
48.32 M
About Cardlytics, Inc. Common Stock
Sector
Industry
CEO
Amit Gupta
Website
Headquarters
Atlanta
Founded
2008
FIGI
BBG00RPL5ZK1
Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CDLX is 81.63 MXN — it has increased by 14.81% in the past 24 hours. Watch CARDLYTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange CARDLYTICS INC stocks are traded under the ticker CDLX.
We've gathered analysts' opinions on CARDLYTICS INC future price: according to them, CDLX price has a max estimate of 100.97 MXN and a min estimate of 80.78 MXN. Watch CDLX chart and read a more detailed CARDLYTICS INC stock forecast: see what analysts think of CARDLYTICS INC and suggest that you do with its stocks.
CDLX reached its all-time high on Feb 22, 2021 with the price of 3,115.00 MXN, and its all-time low was 71.10 MXN and was reached on Sep 23, 2024. View more price dynamics on CDLX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CDLX stock is 12.90% volatile and has beta coefficient of 1.81. Track CARDLYTICS INC stock price on the chart and check out the list of the most volatile stocks — is CARDLYTICS INC there?
Today CARDLYTICS INC has the market capitalization of 3.94 B, it has increased by 9.38% over the last week.
Yes, you can track CARDLYTICS INC financials in yearly and quarterly reports right on TradingView.
CARDLYTICS INC is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
CDLX earnings for the last quarter are −57.14 MXN per share, whereas the estimation was −11.17 MXN resulting in a −411.76% surprise. The estimated earnings for the next quarter are −9.49 MXN per share. See more details about CARDLYTICS INC earnings.
CARDLYTICS INC revenue for the last quarter amounts to 1.32 B MXN, despite the estimated figure of 1.14 B MXN. In the next quarter, revenue is expected to reach 1.30 B MXN.
CDLX net income for the last quarter is −2.86 B MXN, while the quarter before that showed −78.08 M MXN of net income which accounts for −3.56 K% change. Track more CARDLYTICS INC financial stats to get the full picture.
No, CDLX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 19, 2024, the company has 434.00 employees. See our rating of the largest employees — is CARDLYTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CARDLYTICS INC EBITDA is −684.33 M MXN, and current EBITDA margin is −11.05%. See more stats in CARDLYTICS INC financial statements.
Like other stocks, CDLX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARDLYTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CARDLYTICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CARDLYTICS INC stock shows the sell signal. See more of CARDLYTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.